This section describes the latest changes made to this summary as of the date above
Patients experienced reductions in blood pressure, triglycerides, and fasting glucose, along with improvements in insulin sensitivity
There have also been rare reports of kidney infarction and other severe reactions
[7] [8] References [edit] 1 2 3 GRCh38: Ensembl release 89: ENSG00000243955 Ensembl, May 2017 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000057933 Ensembl, May 2017 "Human PubMed Reference:"
That doesn't mean zero risk for all individuals
Its risk table lists baseline systolic blood pressure under 110 mmHg, pre-existing autonomic dysfunction, poor baseline hydration status, and concurrent antihypertensive use where blood-pressure lowering can compound